Clever Leaves Stock Price, News & Analysis (NASDAQ:CLVR) $2.17 +0.06 (+2.84%) (As of 01:31 PM ET) Add Compare Share Share Today's Range$2.08▼$2.1850-Day Range$1.88▼$3.4952-Week Range$1.72▼$17.25Volume4,454 shsAverage Volume15,008 shsMarket Capitalization$3.80 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media About Clever Leaves Stock (NASDAQ:CLVR)Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, standardized extracts, and oral solutions, as well as tetrahydrocannabinol flower. The company was incorporated in 2017 and is based in Tocancipá, Colombia.Read More CLVR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CLVR Stock News HeadlinesNovember 9, 2023 | msn.comClever Leaves GAAP EPS of -$4.60 misses by $2.50, revenue of $3.8M misses by $1.4MNovember 2, 2023 | finance.yahoo.comClever Leaves to Hold Third Quarter 2023 Conference Call on Thursday, November 9, 2023 at 5:00 p.m. ETNovember 28, 2023 | Edge On The Street (Ad)Americans Now Favor Gold Over Stocks as an Investment VehicleAmericans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges. September 15, 2023 | seekingalpha.comClever Leaves regains compliance with Nasdaq's minimum bid price ruleSeptember 13, 2023 | finance.yahoo.comClever Leaves Regains Compliance with Nasdaq Minimum Bid Price RequirementAugust 31, 2023 | msn.comClever Leaves Holdings (CLVR) Price Target Increased by 2900.00% to 24.48August 30, 2023 | benzinga.comMeet The First Vertically Integrated Medicinal Cannabis Company Certified As Carbon-NeutralAugust 29, 2023 | finance.yahoo.comClever Leaves Cannabis Operations Declared Carbon Neutral; a First for a Vertically Integrated Medicinal Cannabis CompanyNovember 28, 2023 | Edge On The Street (Ad)Americans Now Favor Gold Over Stocks as an Investment VehicleAmericans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges. August 28, 2023 | benzinga.comClever Leaves Fights Back: Bold Moves Secure Its NASDAQ Position Amid Global Cannabis Market UncertaintiesAugust 24, 2023 | finance.yahoo.comClever Leaves Announces 1-For-30 Reverse Stock Split to Aid Compliance with Nasdaq Listing RequirementsAugust 15, 2023 | finance.yahoo.comQ2 2023 Clever Leaves Holdings Inc Earnings CallAugust 15, 2023 | finance.yahoo.comClever Leaves Holdings Inc. (NASDAQ:CLVR) Q2 2023 Earnings Call TranscriptAugust 14, 2023 | benzinga.comClever Leaves Reports 21% Revenue Growth And 10% Gross Profit Rise In 2Q 2023August 14, 2023 | finance.yahoo.comClever Leaves Reports Second Quarter 2023 ResultsAugust 7, 2023 | finance.yahoo.comClever Leaves to Hold Second Quarter 2023 Conference Call on Monday, August 14, 2023 at 5:00 p.m. ETJuly 27, 2023 | benzinga.comClever Leaves Shares Trading Higher On Its Colombian Cannabis Launching In AustraliaJuly 20, 2023 | finance.yahoo.comCLVR - Clever Leaves Holdings Inc.July 6, 2023 | msn.comCanaccord Genuity Reiterates Clever Leaves Holdings (CLVR) Hold RecommendationJuly 5, 2023 | finance.yahoo.comClever Leaves Completes Sale of Processing Assets in Portugal to Curaleaf International SubsidiaryJune 8, 2023 | finance.yahoo.comClever Leaves Holdings Inc.'s (NASDAQ:CLVR) Business And Shares Still Trailing The IndustryMay 30, 2023 | msn.comPartnership Will Supply Medical Cannabis Extracts To Czech Republic & SwitzerlandMay 30, 2023 | finance.yahoo.comClever Leaves and Astrasana Partner to Establish International Supply Agreement For Medical Cannabis Extracts in Czech Republic and SwitzerlandMay 26, 2023 | finance.yahoo.comClever Leaves Reminds Shareholders of its Upcoming Annual Meeting on June 2, 2023May 25, 2023 | msn.comClever Leaves Teams Up With SOMAÍ Pharma., Completes First CBD Extract Shipments To PortugalMay 25, 2023 | finance.yahoo.comClever Leaves Partners with SOMAÍ Pharmaceuticals and Sends First Commercial Shipments to PortugalMay 16, 2023 | finance.yahoo.comClever Leaves Granted Brazilian GMP Certification for Cannabis Products by ANVISASee More Headlines Receive CLVR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Clever Leaves and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today11/28/2023Fiscal Year End12/31/2023Next Earnings (Estimated)4/04/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:CLVR CUSIPN/A CIK1819615 Webwww.cleverleaves.com Phone561-634-7430FaxN/AEmployees400Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($28.1751) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-66,170,000.00 Net Margins-239.35% Pretax Margin-289.73% Return on Equity-57.60% Return on Assets-45.33% Debt Debt-to-Equity Ratio0.03 Current Ratio2.62 Quick Ratio1.49 Sales & Book Value Annual Sales$17.80 million Price / Sales0.21 Cash FlowN/A Price / Cash FlowN/A Book Value$27.81 per share Price / Book0.08Miscellaneous Outstanding Shares1,750,000Free Float1,602,000Market Cap$3.69 million OptionableOptionable Beta1.41 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Andres Fajardo (Age 45)Co-Founder, CEO & Director Comp: $232.02kMr. Henry R. Hague III (Age 51)Chief Financial Officer Comp: $311.02kMr. Julian Wilches (Age 44)Chief Regulatory Officer Comp: $202.49kMr. Gustavo EscobarChief Operating OfficerMs. Marta Pinto LeiteGeneral Counsel & Corporate SecretaryMr. Andrew MillerHead of Business DevelopmentMr. Camilo BohorquezHead of ColombiaMs. Caroline KliessManaging Director of GermanyJackie KeshnerInvestor Relations ExecutiveMore ExecutivesKey CompetitorsEnveric BiosciencesNASDAQ:ENVBGRI BioNASDAQ:GRIObsEvaNASDAQ:OBSVArtelo BiosciencesNASDAQ:ARTLHillstream BioPharmaNASDAQ:HILSView All CompetitorsInsiders & InstitutionsAdvisorShares Investments LLCSold 1,029,567 shares on 11/6/2023Ownership: 2.314%FNY Investment Advisers LLCBought 19,985 shares on 10/10/2023Ownership: 1.315%Andres FajardoSold 97 sharesTotal: $640.20 ($6.60/share)Henry R Hague IIISold 52 sharesTotal: $343.20 ($6.60/share)Julian WilchesSold 27 sharesTotal: $178.20 ($6.60/share)View All Insider TransactionsView All Institutional Transactions CLVR Stock Analysis - Frequently Asked Questions How have CLVR shares performed in 2023? Clever Leaves' stock was trading at $9.21 at the start of the year. Since then, CLVR shares have decreased by 76.4% and is now trading at $2.17. View the best growth stocks for 2023 here. Are investors shorting Clever Leaves? Clever Leaves saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 10,000 shares, a decrease of 35.5% from the October 31st total of 15,500 shares. Based on an average daily volume of 36,800 shares, the short-interest ratio is presently 0.3 days. Currently, 0.8% of the shares of the stock are short sold. View Clever Leaves' Short Interest. When is Clever Leaves' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, April 4th 2024. View our CLVR earnings forecast. What ETFs hold Clever Leaves' stock? ETFs with the largest weight of Clever Leaves (NASDAQ:CLVR) stock in their portfolio include AdvisorShares Pure Cannabis ETF (YOLO).Amplify Seymour Cannabis ETF (CNBS). When did Clever Leaves' stock split? Clever Leaves shares reverse split on the morning of Friday, August 25th 2023. The 1-30 reverse split was announced on Thursday, August 24th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, August 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. What guidance has Clever Leaves issued on next quarter's earnings? Clever Leaves updated its FY 2023 earnings guidance on Thursday, November, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $17.00 million-$18.00 million, compared to the consensus revenue estimate of $20.00 million. Who are Clever Leaves' major shareholders? Clever Leaves' stock is owned by a number of institutional and retail investors. Top institutional investors include AdvisorShares Investments LLC (2.31%), FNY Investment Advisers LLC (1.31%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Andres Fajardo, Henry R Hague III, Julian Wilches and William Muecke. View institutional ownership trends. How do I buy shares of Clever Leaves? Shares of CLVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:CLVR) was last updated on 11/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clever Leaves Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.